nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—FDPS—Cholesterol biosynthesis—DHCR24—Alzheimer's disease	0.0253	0.109	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—A2M—Alzheimer's disease	0.0227	0.0984	CbGpPWpGaD
Alendronate—PTPRE—telencephalon—Alzheimer's disease	0.021	0.0729	CbGeAlD
Alendronate—PTPN4—telencephalon—Alzheimer's disease	0.02	0.0693	CbGeAlD
Alendronate—PTPRS—forebrain—Alzheimer's disease	0.0187	0.0646	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—GAB2—Alzheimer's disease	0.0177	0.0765	CbGpPWpGaD
Alendronate—PTPRS—telencephalon—Alzheimer's disease	0.0172	0.0594	CbGeAlD
Alendronate—FDPS—SREBP signalling—AMFR—Alzheimer's disease	0.0134	0.0579	CbGpPWpGaD
Alendronate—Oesophageal ulcer—Memantine—Alzheimer's disease	0.0129	0.0276	CcSEcCtD
Alendronate—PTPRE—nervous system—Alzheimer's disease	0.0124	0.043	CbGeAlD
Alendronate—ATP6V1A—embryo—Alzheimer's disease	0.0122	0.0421	CbGeAlD
Alendronate—PTPRE—central nervous system—Alzheimer's disease	0.012	0.0414	CbGeAlD
Alendronate—PTPN4—nervous system—Alzheimer's disease	0.0118	0.0409	CbGeAlD
Alendronate—PTPRE—cerebellum—Alzheimer's disease	0.0117	0.0405	CbGeAlD
Alendronate—Retrosternal pain—Rivastigmine—Alzheimer's disease	0.0114	0.0244	CcSEcCtD
Alendronate—PTPN4—central nervous system—Alzheimer's disease	0.0114	0.0394	CbGeAlD
Alendronate—PTPN4—cerebellum—Alzheimer's disease	0.0111	0.0385	CbGeAlD
Alendronate—ATP6V1A—forebrain—Alzheimer's disease	0.0108	0.0372	CbGeAlD
Alendronate—Duodenal ulcer—Donepezil—Alzheimer's disease	0.0107	0.0229	CcSEcCtD
Alendronate—PTPRS—nervous system—Alzheimer's disease	0.0101	0.0351	CbGeAlD
Alendronate—ATP6V1A—telencephalon—Alzheimer's disease	0.00989	0.0342	CbGeAlD
Alendronate—PTPRS—central nervous system—Alzheimer's disease	0.00975	0.0338	CbGeAlD
Alendronate—PTPRS—cerebellum—Alzheimer's disease	0.00953	0.033	CbGeAlD
Alendronate—Duodenal ulcer—Rivastigmine—Alzheimer's disease	0.00952	0.0204	CcSEcCtD
Alendronate—PTPRE—brain—Alzheimer's disease	0.0095	0.0329	CbGeAlD
Alendronate—PTPN4—brain—Alzheimer's disease	0.00903	0.0313	CbGeAlD
Alendronate—Gastric ulcer—Donepezil—Alzheimer's disease	0.00891	0.0191	CcSEcCtD
Alendronate—Transaminases increased—Donepezil—Alzheimer's disease	0.00851	0.0182	CcSEcCtD
Alendronate—Nephrolithiasis—Galantamine—Alzheimer's disease	0.00831	0.0178	CcSEcCtD
Alendronate—FDPS—forebrain—Alzheimer's disease	0.00811	0.0281	CbGeAlD
Alendronate—Gastric ulcer—Memantine—Alzheimer's disease	0.00809	0.0173	CcSEcCtD
Alendronate—ATP6V1A—Transferrin endocytosis and recycling—TF—Alzheimer's disease	0.00797	0.0345	CbGpPWpGaD
Alendronate—Gastric ulcer—Rivastigmine—Alzheimer's disease	0.00792	0.0169	CcSEcCtD
Alendronate—PTPRS—brain—Alzheimer's disease	0.00774	0.0268	CbGeAlD
Alendronate—FDPS—telencephalon—Alzheimer's disease	0.00745	0.0258	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS2—Alzheimer's disease	0.00708	0.0307	CbGpPWpGaD
Alendronate—Histamine Phosphate—CA4—Alzheimer's disease	0.00699	0.532	CrCbGaD
Alendronate—ATP6V1A—Iron uptake and transport—CP—Alzheimer's disease	0.00684	0.0296	CbGpPWpGaD
Alendronate—Influenza-like symptoms—Memantine—Alzheimer's disease	0.00658	0.0141	CcSEcCtD
Alendronate—Melaena—Galantamine—Alzheimer's disease	0.00653	0.014	CcSEcCtD
Alendronate—Influenza-like symptoms—Rivastigmine—Alzheimer's disease	0.00644	0.0138	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—TTR—Alzheimer's disease	0.00614	0.0266	CbGpPWpGaD
Alendronate—Nephrolithiasis—Memantine—Alzheimer's disease	0.00585	0.0125	CcSEcCtD
Alendronate—ATP6V1A—nervous system—Alzheimer's disease	0.00584	0.0202	CbGeAlD
Alendronate—ATP6V1A—Iron uptake and transport—TF—Alzheimer's disease	0.00582	0.0252	CbGpPWpGaD
Alendronate—Nephrolithiasis—Rivastigmine—Alzheimer's disease	0.00572	0.0122	CcSEcCtD
Alendronate—ATP6V1A—central nervous system—Alzheimer's disease	0.00562	0.0195	CbGeAlD
Alendronate—ATP6V1A—cerebellum—Alzheimer's disease	0.0055	0.019	CbGeAlD
Alendronate—Gastrooesophageal reflux disease—Memantine—Alzheimer's disease	0.00521	0.0111	CcSEcCtD
Alendronate—Gastrooesophageal reflux disease—Rivastigmine—Alzheimer's disease	0.00509	0.0109	CcSEcCtD
Alendronate—Melaena—Donepezil—Alzheimer's disease	0.00506	0.0108	CcSEcCtD
Alendronate—Oesophagitis—Donepezil—Alzheimer's disease	0.00473	0.0101	CcSEcCtD
Alendronate—Melaena—Memantine—Alzheimer's disease	0.00459	0.00983	CcSEcCtD
Alendronate—Influenza like illness—Memantine—Alzheimer's disease	0.00457	0.00978	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—ADAMTS4—Alzheimer's disease	0.00457	0.0198	CbGpPWpGaD
Alendronate—Melaena—Rivastigmine—Alzheimer's disease	0.00449	0.00962	CcSEcCtD
Alendronate—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00447	0.00956	CcSEcCtD
Alendronate—ATP6V1A—brain—Alzheimer's disease	0.00446	0.0155	CbGeAlD
Alendronate—FDPS—nervous system—Alzheimer's disease	0.0044	0.0152	CbGeAlD
Alendronate—Oesophagitis—Memantine—Alzheimer's disease	0.0043	0.0092	CcSEcCtD
Alendronate—Gastritis—Galantamine—Alzheimer's disease	0.00429	0.00919	CcSEcCtD
Alendronate—FDPS—central nervous system—Alzheimer's disease	0.00424	0.0147	CbGeAlD
Alendronate—Oesophagitis—Rivastigmine—Alzheimer's disease	0.0042	0.009	CcSEcCtD
Alendronate—Dysphagia—Galantamine—Alzheimer's disease	0.00419	0.00897	CcSEcCtD
Alendronate—FDPS—cerebellum—Alzheimer's disease	0.00414	0.0143	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—PSEN1—Alzheimer's disease	0.00413	0.0179	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—HMOX1—Alzheimer's disease	0.00407	0.0176	CbGpPWpGaD
Alendronate—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00402	0.0086	CcSEcCtD
Alendronate—ATP6V1A—Insulin receptor recycling—INS—Alzheimer's disease	0.00398	0.0173	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—NCSTN—Alzheimer's disease	0.00391	0.0169	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—Alzheimer's disease	0.00387	0.0167	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—AKT1—Alzheimer's disease	0.00357	0.0155	CbGpPWpGaD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—Alzheimer's disease	0.00351	0.0152	CbGpPWpGaD
Alendronate—Dry skin—Donepezil—Alzheimer's disease	0.00345	0.00738	CcSEcCtD
Alendronate—Cramp muscle—Donepezil—Alzheimer's disease	0.00339	0.00725	CcSEcCtD
Alendronate—Haemoglobin—Galantamine—Alzheimer's disease	0.00337	0.00722	CcSEcCtD
Alendronate—FDPS—brain—Alzheimer's disease	0.00336	0.0116	CbGeAlD
Alendronate—Haemorrhage—Galantamine—Alzheimer's disease	0.00336	0.00718	CcSEcCtD
Alendronate—Gastritis—Donepezil—Alzheimer's disease	0.00333	0.00712	CcSEcCtD
Alendronate—Oedema peripheral—Galantamine—Alzheimer's disease	0.00331	0.00708	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—A2M—Alzheimer's disease	0.00328	0.0142	CbGpPWpGaD
Alendronate—Abdominal distension—Donepezil—Alzheimer's disease	0.00327	0.007	CcSEcCtD
Alendronate—Asthma—Donepezil—Alzheimer's disease	0.00325	0.00696	CcSEcCtD
Alendronate—Dysphagia—Donepezil—Alzheimer's disease	0.00325	0.00696	CcSEcCtD
Alendronate—Dry skin—Memantine—Alzheimer's disease	0.00313	0.0067	CcSEcCtD
Alendronate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00311	0.00667	CcSEcCtD
Alendronate—Dry skin—Rivastigmine—Alzheimer's disease	0.00306	0.00655	CcSEcCtD
Alendronate—Gastritis—Memantine—Alzheimer's disease	0.00302	0.00647	CcSEcCtD
Alendronate—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00301	0.00644	CcSEcCtD
Alendronate—Gastritis—Rivastigmine—Alzheimer's disease	0.00296	0.00633	CcSEcCtD
Alendronate—Asthma—Memantine—Alzheimer's disease	0.00295	0.00631	CcSEcCtD
Alendronate—Dysphagia—Memantine—Alzheimer's disease	0.00295	0.00631	CcSEcCtD
Alendronate—FDPS—SREBP signalling—GSK3A—Alzheimer's disease	0.00289	0.0125	CbGpPWpGaD
Alendronate—Dysphagia—Rivastigmine—Alzheimer's disease	0.00289	0.00618	CcSEcCtD
Alendronate—Flatulence—Galantamine—Alzheimer's disease	0.00288	0.00616	CcSEcCtD
Alendronate—Dysgeusia—Galantamine—Alzheimer's disease	0.00286	0.00612	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—Alzheimer's disease	0.00282	0.0122	CbGpPWpGaD
Alendronate—Muscle spasms—Galantamine—Alzheimer's disease	0.00281	0.00601	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—CTSB—Alzheimer's disease	0.00271	0.0118	CbGpPWpGaD
Alendronate—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00271	0.0058	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—CTSD—Alzheimer's disease	0.0027	0.0117	CbGpPWpGaD
Alendronate—Anaemia—Galantamine—Alzheimer's disease	0.0027	0.00578	CcSEcCtD
Alendronate—Malaise—Galantamine—Alzheimer's disease	0.00263	0.00564	CcSEcCtD
Alendronate—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00263	0.00564	CcSEcCtD
Alendronate—Vertigo—Galantamine—Alzheimer's disease	0.00262	0.00562	CcSEcCtD
Alendronate—Haemoglobin—Donepezil—Alzheimer's disease	0.00261	0.0056	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00261	0.00558	CcSEcCtD
Alendronate—Haemorrhage—Donepezil—Alzheimer's disease	0.0026	0.00557	CcSEcCtD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—Alzheimer's disease	0.0026	0.0113	CbGpPWpGaD
Alendronate—Oedema peripheral—Donepezil—Alzheimer's disease	0.00256	0.00548	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00255	0.00546	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.0025	0.0108	CbGpPWpGaD
Alendronate—Myalgia—Galantamine—Alzheimer's disease	0.00249	0.00532	CcSEcCtD
Alendronate—Chest pain—Galantamine—Alzheimer's disease	0.00249	0.00532	CcSEcCtD
Alendronate—Discomfort—Galantamine—Alzheimer's disease	0.00246	0.00526	CcSEcCtD
Alendronate—Haemoglobin—Memantine—Alzheimer's disease	0.00237	0.00508	CcSEcCtD
Alendronate—Haemorrhage—Memantine—Alzheimer's disease	0.00236	0.00505	CcSEcCtD
Alendronate—Risedronate—PTGS2—Alzheimer's disease	0.00233	0.178	CrCbGaD
Alendronate—Oedema peripheral—Memantine—Alzheimer's disease	0.00233	0.00498	CcSEcCtD
Alendronate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00232	0.00497	CcSEcCtD
Alendronate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00231	0.00494	CcSEcCtD
Alendronate—Alopecia—Donepezil—Alzheimer's disease	0.0023	0.00492	CcSEcCtD
Alendronate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00228	0.00487	CcSEcCtD
Alendronate—Erythema—Donepezil—Alzheimer's disease	0.00226	0.00485	CcSEcCtD
Alendronate—Erythema multiforme—Memantine—Alzheimer's disease	0.00223	0.00478	CcSEcCtD
Alendronate—Flatulence—Donepezil—Alzheimer's disease	0.00223	0.00478	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00223	0.00965	CbGpPWpGaD
Alendronate—Dysgeusia—Donepezil—Alzheimer's disease	0.00222	0.00475	CcSEcCtD
Alendronate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00218	0.00468	CcSEcCtD
Alendronate—Muscle spasms—Donepezil—Alzheimer's disease	0.00218	0.00466	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00217	0.00465	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—ADAM10—Alzheimer's disease	0.00214	0.00926	CbGpPWpGaD
Alendronate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.0021	0.0045	CcSEcCtD
Alendronate—Dyspepsia—Galantamine—Alzheimer's disease	0.0021	0.00449	CcSEcCtD
Alendronate—Anaemia—Donepezil—Alzheimer's disease	0.00209	0.00448	CcSEcCtD
Alendronate—Alopecia—Memantine—Alzheimer's disease	0.00209	0.00447	CcSEcCtD
Alendronate—Clodronate—PTGS2—Alzheimer's disease	0.00208	0.158	CrCbGaD
Alendronate—Malaise—Donepezil—Alzheimer's disease	0.00204	0.00437	CcSEcCtD
Alendronate—Alopecia—Rivastigmine—Alzheimer's disease	0.00204	0.00437	CcSEcCtD
Alendronate—Constipation—Galantamine—Alzheimer's disease	0.00204	0.00436	CcSEcCtD
Alendronate—FDPS—SREBP signalling—LPL—Alzheimer's disease	0.00204	0.00883	CbGpPWpGaD
Alendronate—Vertigo—Donepezil—Alzheimer's disease	0.00203	0.00435	CcSEcCtD
Alendronate—Flatulence—Memantine—Alzheimer's disease	0.00203	0.00434	CcSEcCtD
Alendronate—Dysgeusia—Memantine—Alzheimer's disease	0.00201	0.00431	CcSEcCtD
Alendronate—Erythema—Rivastigmine—Alzheimer's disease	0.00201	0.0043	CcSEcCtD
Alendronate—Flatulence—Rivastigmine—Alzheimer's disease	0.00198	0.00424	CcSEcCtD
Alendronate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00197	0.00422	CcSEcCtD
Alendronate—Feeling abnormal—Galantamine—Alzheimer's disease	0.00196	0.00421	CcSEcCtD
Alendronate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00195	0.00417	CcSEcCtD
Alendronate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00193	0.00414	CcSEcCtD
Alendronate—Chest pain—Donepezil—Alzheimer's disease	0.00193	0.00413	CcSEcCtD
Alendronate—Myalgia—Donepezil—Alzheimer's disease	0.00193	0.00413	CcSEcCtD
Alendronate—Ill-defined disorder—Memantine—Alzheimer's disease	0.00191	0.00408	CcSEcCtD
Alendronate—Discomfort—Donepezil—Alzheimer's disease	0.0019	0.00408	CcSEcCtD
Alendronate—Anaemia—Memantine—Alzheimer's disease	0.0019	0.00407	CcSEcCtD
Alendronate—Body temperature increased—Galantamine—Alzheimer's disease	0.00188	0.00403	CcSEcCtD
Alendronate—Abdominal pain—Galantamine—Alzheimer's disease	0.00188	0.00403	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00187	0.00811	CbGpPWpGaD
Alendronate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00187	0.00399	CcSEcCtD
Alendronate—Anaemia—Rivastigmine—Alzheimer's disease	0.00186	0.00398	CcSEcCtD
Alendronate—Malaise—Memantine—Alzheimer's disease	0.00185	0.00397	CcSEcCtD
Alendronate—Vertigo—Memantine—Alzheimer's disease	0.00185	0.00395	CcSEcCtD
Alendronate—Infection—Donepezil—Alzheimer's disease	0.00184	0.00393	CcSEcCtD
Alendronate—Malaise—Rivastigmine—Alzheimer's disease	0.00181	0.00388	CcSEcCtD
Alendronate—Vertigo—Rivastigmine—Alzheimer's disease	0.00181	0.00387	CcSEcCtD
Alendronate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00176	0.00376	CcSEcCtD
Alendronate—Myalgia—Memantine—Alzheimer's disease	0.00175	0.00375	CcSEcCtD
Alendronate—Chest pain—Memantine—Alzheimer's disease	0.00175	0.00375	CcSEcCtD
Alendronate—Histamine Phosphate—CYP2D6—Alzheimer's disease	0.00173	0.132	CrCbGaD
Alendronate—Discomfort—Memantine—Alzheimer's disease	0.00173	0.0037	CcSEcCtD
Alendronate—Myalgia—Rivastigmine—Alzheimer's disease	0.00171	0.00366	CcSEcCtD
Alendronate—Chest pain—Rivastigmine—Alzheimer's disease	0.00171	0.00366	CcSEcCtD
Alendronate—Asthenia—Galantamine—Alzheimer's disease	0.00171	0.00366	CcSEcCtD
Alendronate—Discomfort—Rivastigmine—Alzheimer's disease	0.00169	0.00362	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00168	0.0036	CcSEcCtD
Alendronate—Infection—Memantine—Alzheimer's disease	0.00167	0.00357	CcSEcCtD
Alendronate—Diarrhoea—Galantamine—Alzheimer's disease	0.00163	0.00349	CcSEcCtD
Alendronate—Infection—Rivastigmine—Alzheimer's disease	0.00163	0.00349	CcSEcCtD
Alendronate—Dyspepsia—Donepezil—Alzheimer's disease	0.00163	0.00348	CcSEcCtD
Alendronate—Constipation—Donepezil—Alzheimer's disease	0.00158	0.00338	CcSEcCtD
Alendronate—Pain—Donepezil—Alzheimer's disease	0.00158	0.00338	CcSEcCtD
Alendronate—Dizziness—Galantamine—Alzheimer's disease	0.00158	0.00337	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00154	0.00669	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00153	0.00327	CcSEcCtD
Alendronate—Feeling abnormal—Donepezil—Alzheimer's disease	0.00152	0.00326	CcSEcCtD
Alendronate—Vomiting—Galantamine—Alzheimer's disease	0.00152	0.00324	CcSEcCtD
Alendronate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00151	0.00323	CcSEcCtD
Alendronate—Rash—Galantamine—Alzheimer's disease	0.0015	0.00322	CcSEcCtD
Alendronate—Dermatitis—Galantamine—Alzheimer's disease	0.0015	0.00321	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0015	0.0032	CcSEcCtD
Alendronate—Headache—Galantamine—Alzheimer's disease	0.00149	0.0032	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PPARG—Alzheimer's disease	0.00149	0.00645	CbGpPWpGaD
Alendronate—Dyspepsia—Memantine—Alzheimer's disease	0.00148	0.00316	CcSEcCtD
Alendronate—Urticaria—Donepezil—Alzheimer's disease	0.00147	0.00314	CcSEcCtD
Alendronate—FDPS—SREBP signalling—CREB1—Alzheimer's disease	0.00147	0.00636	CbGpPWpGaD
Alendronate—Body temperature increased—Donepezil—Alzheimer's disease	0.00146	0.00313	CcSEcCtD
Alendronate—Abdominal pain—Donepezil—Alzheimer's disease	0.00146	0.00313	CcSEcCtD
Alendronate—FDPS—SREBP signalling—INS—Alzheimer's disease	0.00146	0.00632	CbGpPWpGaD
Alendronate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00144	0.00309	CcSEcCtD
Alendronate—Pain—Memantine—Alzheimer's disease	0.00143	0.00307	CcSEcCtD
Alendronate—Constipation—Memantine—Alzheimer's disease	0.00143	0.00307	CcSEcCtD
Alendronate—Nausea—Galantamine—Alzheimer's disease	0.00142	0.00303	CcSEcCtD
Alendronate—Constipation—Rivastigmine—Alzheimer's disease	0.0014	0.003	CcSEcCtD
Alendronate—Pain—Rivastigmine—Alzheimer's disease	0.0014	0.003	CcSEcCtD
Alendronate—Feeling abnormal—Memantine—Alzheimer's disease	0.00138	0.00296	CcSEcCtD
Alendronate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00137	0.00294	CcSEcCtD
Alendronate—Hypersensitivity—Donepezil—Alzheimer's disease	0.00136	0.00291	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.00135	0.00586	CbGpPWpGaD
Alendronate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00135	0.00289	CcSEcCtD
Alendronate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00134	0.00287	CcSEcCtD
Alendronate—Urticaria—Memantine—Alzheimer's disease	0.00133	0.00285	CcSEcCtD
Alendronate—Abdominal pain—Memantine—Alzheimer's disease	0.00133	0.00284	CcSEcCtD
Alendronate—Body temperature increased—Memantine—Alzheimer's disease	0.00133	0.00284	CcSEcCtD
Alendronate—Asthenia—Donepezil—Alzheimer's disease	0.00133	0.00284	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00131	0.00568	CbGpPWpGaD
Alendronate—Pruritus—Donepezil—Alzheimer's disease	0.00131	0.0028	CcSEcCtD
Alendronate—Urticaria—Rivastigmine—Alzheimer's disease	0.0013	0.00279	CcSEcCtD
Alendronate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.0013	0.00278	CcSEcCtD
Alendronate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0013	0.00278	CcSEcCtD
Alendronate—Diarrhoea—Donepezil—Alzheimer's disease	0.00126	0.00271	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00125	0.00541	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ITM2B—Alzheimer's disease	0.00125	0.00539	CbGpPWpGaD
Alendronate—Hypersensitivity—Memantine—Alzheimer's disease	0.00124	0.00265	CcSEcCtD
Alendronate—Dizziness—Donepezil—Alzheimer's disease	0.00122	0.00262	CcSEcCtD
Alendronate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00121	0.00259	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INS—Alzheimer's disease	0.0012	0.00522	CbGpPWpGaD
Alendronate—Asthenia—Memantine—Alzheimer's disease	0.0012	0.00258	CcSEcCtD
Alendronate—Pruritus—Memantine—Alzheimer's disease	0.00119	0.00254	CcSEcCtD
Alendronate—Asthenia—Rivastigmine—Alzheimer's disease	0.00118	0.00252	CcSEcCtD
Alendronate—Vomiting—Donepezil—Alzheimer's disease	0.00117	0.00251	CcSEcCtD
Alendronate—Rash—Donepezil—Alzheimer's disease	0.00117	0.00249	CcSEcCtD
Alendronate—Dermatitis—Donepezil—Alzheimer's disease	0.00116	0.00249	CcSEcCtD
Alendronate—Pruritus—Rivastigmine—Alzheimer's disease	0.00116	0.00249	CcSEcCtD
Alendronate—Headache—Donepezil—Alzheimer's disease	0.00116	0.00248	CcSEcCtD
Alendronate—Diarrhoea—Memantine—Alzheimer's disease	0.00115	0.00246	CcSEcCtD
Alendronate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00112	0.0024	CcSEcCtD
Alendronate—Dizziness—Memantine—Alzheimer's disease	0.00111	0.00237	CcSEcCtD
Alendronate—Nausea—Donepezil—Alzheimer's disease	0.0011	0.00235	CcSEcCtD
Alendronate—Dizziness—Rivastigmine—Alzheimer's disease	0.00109	0.00232	CcSEcCtD
Alendronate—Vomiting—Memantine—Alzheimer's disease	0.00107	0.00228	CcSEcCtD
Alendronate—Rash—Memantine—Alzheimer's disease	0.00106	0.00226	CcSEcCtD
Alendronate—Dermatitis—Memantine—Alzheimer's disease	0.00106	0.00226	CcSEcCtD
Alendronate—Headache—Memantine—Alzheimer's disease	0.00105	0.00225	CcSEcCtD
Alendronate—Vomiting—Rivastigmine—Alzheimer's disease	0.00104	0.00223	CcSEcCtD
Alendronate—Rash—Rivastigmine—Alzheimer's disease	0.00103	0.00222	CcSEcCtD
Alendronate—Dermatitis—Rivastigmine—Alzheimer's disease	0.00103	0.00221	CcSEcCtD
Alendronate—Headache—Rivastigmine—Alzheimer's disease	0.00103	0.0022	CcSEcCtD
Alendronate—Nausea—Memantine—Alzheimer's disease	0.000997	0.00213	CcSEcCtD
Alendronate—ATP6V1A—Disease—GAPDHS—Alzheimer's disease	0.000995	0.00431	CbGpPWpGaD
Alendronate—Nausea—Rivastigmine—Alzheimer's disease	0.000975	0.00209	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—CASP3—Alzheimer's disease	0.000951	0.00412	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TTR—Alzheimer's disease	0.000863	0.00374	CbGpPWpGaD
Alendronate—FDPS—Metabolism—DHCR24—Alzheimer's disease	0.000834	0.00361	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000824	0.00357	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000777	0.00337	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—Alzheimer's disease	0.000741	0.00321	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA4—Alzheimer's disease	0.000709	0.00307	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000701	0.00304	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000693	0.003	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GAPDHS—Alzheimer's disease	0.000666	0.00289	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SNCA—Alzheimer's disease	0.000641	0.00278	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ATP5A1—Alzheimer's disease	0.000632	0.00274	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TTR—Alzheimer's disease	0.000604	0.00262	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLD3—Alzheimer's disease	0.000603	0.00261	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000603	0.00261	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000596	0.00258	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—AKT1—Alzheimer's disease	0.000588	0.00255	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD17B10—Alzheimer's disease	0.000578	0.0025	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PSENEN—Alzheimer's disease	0.000572	0.00248	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000565	0.00245	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APH1A—Alzheimer's disease	0.000564	0.00244	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP46A1—Alzheimer's disease	0.000556	0.00241	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NCSTN—Alzheimer's disease	0.000549	0.00238	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ND1—Alzheimer's disease	0.000537	0.00233	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LRP1—Alzheimer's disease	0.000535	0.00232	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PYY—Alzheimer's disease	0.000528	0.00229	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—Alzheimer's disease	0.000526	0.00228	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000525	0.00227	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TPI1—Alzheimer's disease	0.000517	0.00224	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.00049	0.00212	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EIF2AK2—Alzheimer's disease	0.000486	0.00211	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.00048	0.00208	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GAPDH—Alzheimer's disease	0.000477	0.00207	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDK5—Alzheimer's disease	0.000458	0.00198	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PSEN2—Alzheimer's disease	0.000446	0.00193	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR6—Alzheimer's disease	0.000441	0.00191	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CST3—Alzheimer's disease	0.000436	0.00189	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000414	0.00179	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IAPP—Alzheimer's disease	0.000408	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PSENEN—Alzheimer's disease	0.0004	0.00173	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APH1A—Alzheimer's disease	0.000395	0.00171	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000384	0.00167	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000377	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ENO1—Alzheimer's disease	0.000376	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LRP1—Alzheimer's disease	0.000375	0.00162	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PPP3CA—Alzheimer's disease	0.000374	0.00162	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GAL—Alzheimer's disease	0.000366	0.00159	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GFAP—Alzheimer's disease	0.000366	0.00159	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GAB2—Alzheimer's disease	0.000358	0.00155	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GSK3A—Alzheimer's disease	0.000355	0.00154	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APP—Alzheimer's disease	0.000349	0.00151	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CHAT—Alzheimer's disease	0.000346	0.0015	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TPI1—Alzheimer's disease	0.000346	0.0015	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MAOB—Alzheimer's disease	0.000332	0.00144	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—A2M—Alzheimer's disease	0.000323	0.0014	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GAPDH—Alzheimer's disease	0.000319	0.00138	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000316	0.00137	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000313	0.00136	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000313	0.00135	CbGpPWpGaD
Alendronate—FDPS—Metabolism—A2M—Alzheimer's disease	0.000309	0.00134	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADAM10—Alzheimer's disease	0.0003	0.0013	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NPY—Alzheimer's disease	0.000288	0.00125	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000286	0.00124	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CRH—Alzheimer's disease	0.000277	0.0012	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000275	0.00119	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACHE—Alzheimer's disease	0.000268	0.00116	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INPP5D—Alzheimer's disease	0.000265	0.00115	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NPS—Alzheimer's disease	0.000263	0.00114	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000262	0.00113	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000258	0.00112	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS1—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO1—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SST—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LPL—Alzheimer's disease	0.000251	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000249	0.00108	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2D6—Alzheimer's disease	0.000247	0.00107	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APP—Alzheimer's disease	0.000245	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKCG—Alzheimer's disease	0.000244	0.00106	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BCHE—Alzheimer's disease	0.000234	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CCR5—Alzheimer's disease	0.000231	0.001	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000231	0.001	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—Alzheimer's disease	0.000226	0.000978	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLCB1—Alzheimer's disease	0.000221	0.000956	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000216	0.000938	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000215	0.000933	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCA1—Alzheimer's disease	0.000214	0.000926	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CALM1—Alzheimer's disease	0.000211	0.000913	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.00021	0.000911	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—Alzheimer's disease	0.00021	0.00091	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CAV1—Alzheimer's disease	0.000208	0.000902	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—S100B—Alzheimer's disease	0.000199	0.000862	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—Alzheimer's disease	0.000196	0.000848	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOTCH1—Alzheimer's disease	0.000194	0.00084	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000189	0.00082	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARGC1A—Alzheimer's disease	0.000184	0.000799	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—Alzheimer's disease	0.000183	0.000795	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000183	0.000793	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GSK3B—Alzheimer's disease	0.000182	0.000788	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CREB1—Alzheimer's disease	0.00018	0.000782	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—Alzheimer's disease	0.000179	0.000778	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LPL—Alzheimer's disease	0.000176	0.00076	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000174	0.000754	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000171	0.000739	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPL—Alzheimer's disease	0.000168	0.000727	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGF—Alzheimer's disease	0.000166	0.00072	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR5—Alzheimer's disease	0.000162	0.000701	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000158	0.000686	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—Alzheimer's disease	0.000157	0.000682	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—Alzheimer's disease	0.000151	0.000655	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CALM1—Alzheimer's disease	0.000148	0.00064	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—Alzheimer's disease	0.000147	0.000637	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—Alzheimer's disease	0.000147	0.000637	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CAV1—Alzheimer's disease	0.000146	0.000632	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—Alzheimer's disease	0.000144	0.000624	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CALM1—Alzheimer's disease	0.000141	0.000612	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—Alzheimer's disease	0.000141	0.000609	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—Alzheimer's disease	0.00014	0.000609	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAV1—Alzheimer's disease	0.000139	0.000604	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—F2—Alzheimer's disease	0.000139	0.000601	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000136	0.000588	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GSK3B—Alzheimer's disease	0.000127	0.000552	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREB1—Alzheimer's disease	0.000126	0.000548	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—Alzheimer's disease	0.000126	0.000545	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL2—Alzheimer's disease	0.000124	0.000536	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—Alzheimer's disease	0.000123	0.000531	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—Alzheimer's disease	0.000122	0.000527	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—Alzheimer's disease	0.00012	0.000521	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—Alzheimer's disease	0.00011	0.000478	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—Alzheimer's disease	0.000105	0.000457	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—Alzheimer's disease	0.000104	0.000451	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—Alzheimer's disease	9.64e-05	0.000418	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—Alzheimer's disease	9.36e-05	0.000405	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—Alzheimer's disease	8.6e-05	0.000373	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—Alzheimer's disease	7.94e-05	0.000344	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—Alzheimer's disease	7.84e-05	0.00034	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—Alzheimer's disease	7.29e-05	0.000316	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—Alzheimer's disease	7.23e-05	0.000313	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—Alzheimer's disease	6e-05	0.00026	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—Alzheimer's disease	5.49e-05	0.000238	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—Alzheimer's disease	5.07e-05	0.00022	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—Alzheimer's disease	4.84e-05	0.00021	CbGpPWpGaD
